In Press
First available online: 2025-08-02
First available online: 2025-08-02
Serum Pentraxin 3 level in Egyptian patients with nonalcoholic fatty liver disease and type 2 diabetes
First available online: 2025-08-05
Development and Validation of a Smoking Behavior Instrument Using the Content Validity Index (CVI) Within the Theory of Planned Behaviour (TPB) Framework
First available online: 2025-08-07
Trifluorooxoacetamido Benzamides as Breakthrough CETP Inhibitors: A Synergistic Approach of Synthesis, Biological Assessment, and Molecular Modeling
First available online: 2025-08-07
The Attitudes of Palestinian Healthcare Students Towards People with Disabilities: Designing and Statistically Validating an Inventory
First available online: 2025-08-07
Authors:
Design, Molecular Docking, Molecular Dynamics, and Evaluation of Novel Ligands Targeting Beta-2 Adrenergic Receptor for Asthma Therapeutics
First available online: 2025-08-10
Authors:
Chemical Composition, Antioxidant Activity, and In Silico Pharmacokinetics of Essential Oils from Four Ocimum basilicum Cultivars in Iraq
First available online: 2025-08-20
Since 2022
Cite Score (Scopus): 0.8
Time to First Decision: 3 Days
Submission to Acceptance: 45 Days
Acceptance to Publication: 64 Days
Acceptance Rate: 17%
Why should you
Publish With Us?
An-Najah National University
Nablus, Palestine
Nablus, Palestine
- P.O. Box
- 7, 707
- Fax
- (970)(9)2345982
- Tel.
- (970)(9)2345560
- (970)(9)2345113/5/6/7-Ext. 2628
- [email protected]
- EIC
- Prof. Waleed Sweileh
The Palestinian Medical and Pharmaceutical Journal (Pal. Med. Pharm. J.) © 2024 by An-Najah University, Nablus, Palestine is licensed under CC BY-NC 4.0
News and Views